Dr. McCullough is an internist, cardiologist, epidemiologist holding degrees from Baylor University, University of Texas Southwestern Medical School, University of Michigan, and Southern Methodist University.  He manages common infectious diseases as well as the cardiovascular complications of both the viral infection and the injuries developing after the COVID-19 vaccine in Dallas TX, USA. Dr. McCullough has broadly published on a range of topics in medicine with > 1000 publications and > 685 citations in the National Library of Medicine.  His works include “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” the first widely utilized treatment regimen for ambulatory patients infected with SARS-CoV-2 in the American Journal of Medicine and subsequently updated in Reviews in Cardiovascular Medicine.  Subsequently he published the first detoxification approach titled “Clinical Rationale for SARS-CoV-2 Base Spike Protein Detoxification in Post COVID-19 and Vaccine Injury Syndromes” in the Journal of American Physicians and Surgeons.  He has dozens of peer-reviewed publications on the infection and has commented extensively on the medical response to the COVID-19 crisis in TheHill, America Out Loud, and on FOX NEWS Channel.  Dr. McCullough testified multiple times in the US Senate, Texas Senate Committee on Health and Human Services, Arizona Senate and House of Representatives, Colorado General Assembly, New Hampshire Senate, Pennsylvania Senate, and South Carolina Senate concerning many aspects of the pandemic response.  Dr. McCullough has had years of dedicated academic and clinical efforts in combating the SARS-CoV-2 virus and in doing so, has reviewed thousands of reports, participated in scientific congresses, group discussions, press releases, and has been considered among the world's experts on COVID-19.   Dr. Peter McCullough, www.petermcculloughmd.com President, McCullough Foundation, www.mcculloughfnd.org Author, Courage to Face COVID-19, www.couragetofacecovid.com Radio Show,  www.americaoutloud.com/author/dr-peter-mccullough/ Substack,  petermcculloughmd.substack.com/ Subscribe to my Substack, Fringe Finance, here: http://quoththeraven.substack.com Podcast listeners can take 50% off a Substack annual subscription for life by using this link: https://quoththeraven.substack.com/subscribe?coupon=92245385 Contribute a paltry recurring donation via Patreon: https://www.patreon.com/QTRResearch One time donations can also be sent via PayPal: https://www.paypal.me/qtrresearch QTR merch is available here. You can also follow me on YouTube, and Twitter. THANK YOU TO ALL OF MY KIND PATRONS.    Please show love to those who support the QTR Podcast:  Masterworks - use code QTR at Masterworks.com to skip the waiting list JM Bullion - where QTR buys gold & silver - Twitter: @JMBullion George Gammon - Rebel Capitalist Pro - Twitter: @GeorgeGammon Sang Lucci & Wall St. Jesus — The Steamroom — Twitter: @wallstjesus and @sanglucci Longest Running Supporters   Max Mulvihill - Since 2/2018  Mark Heywood - Since 3/2018 Kyle Thomas - Since 4/2018  Chris Bede - Since 5/2018  Dariusz Kordonski - Since 5/2018  Chris Gerrard - Since 5/2018 Shear Luck - Since 5/2018   Founding Members Of My "FRINGE FINANCE" Column Kashumba - Since 8/2021 Randy Carder - Since 8/2021 T Gaggiotti - Since 8/2021 Jamie - Since 8/2021 A Farmer - Since 9/2021 Harvest Moon Research - Since 9/2021 John H. H. - Since 11/2021 Mark Hutchinson - Since 11/2021 Joseph K. H. - Since 10/2021 A Farmer - Since 9/2021 Tsniezyk - Since 9/2021 Chris - Since 12/2021 All podcast content is subject to this disclaimer.    Chris is not an investment adviser. Listeners should always speak to their personal financial advisers. Please leave me alone. Masterworks Disclaimer: This is not an offer of a security or investment advice. See important disclosures at masterworks.com/cd View all past offerings here When Masterworks presents the net return of an investment in a sold artwork, “net return” or “IRR” refers to the annualized internal rate of return net of all fees and expenses, calculated from the offering closing date to the date the sale is consummated. IRR is not indicative of Masterworks paintings not yet sold and past performance is not indicative of future results. For additional information regarding the calculation of IRR for a particular investment in an artwork that has been sold, a reconciliation will be filed as an exhibit to Form 1-U and will be available on the SEC’s website at www.sec.gov.